| 99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology A Campennì, L Giovanella, M Siracusa, A Alibrandi, SA Pignata, ... Thyroid 26 (8), 1101-1109, 2016 | 59 | 2016 |
| Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients A Campennì, L Giovanella, SA Pignata, A Vento, A Alibrandi, L Sturiale, ... Oncotarget 9 (25), 17491, 2018 | 47 | 2018 |
| Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy A Campennì, M Siracusa, RM Ruggeri, R Laudicella, SA Pignata, ... Scientific reports 7 (1), 6147, 2017 | 43 | 2017 |
| Association of parathyroid carcinoma and thyroid disorders: A clinical review A Campennì, S Giovinazzo, SA Pignata, F Di Mauro, D Santoro, L Curtò, ... Endocrine 56, 19-26, 2017 | 31 | 2017 |
| Association of upfront peptide receptor radionuclide therapy with progression-free survival among patients with enteropancreatic neuroendocrine tumors S Pusceddu, N Prinzi, S Tafuto, T Ibrahim, A Filice, MP Brizzi, F Panzuto, ... JAMA network open 5 (2), e220290-e220290, 2022 | 26 | 2022 |
| Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario A Campennì, L Giovanella, SA Pignata, MA Violi, M Siracusa, A Alibrandi, ... Nuclear Medicine Communications 36 (11), 1100-1106, 2015 | 26 | 2015 |
| The Additional Value of 18F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020 N Quartuccio, R Laudicella, A Vento, S Pignata, MV Mattoli, R Filice, ... Diagnostics 10 (6), 357, 2020 | 23 | 2020 |
| Role of molecular imaging in the management of patients affected by inflammatory bowel disease: state-of-the-art F Caobelli, L Evangelista, N Quartuccio, D Familiari, C Altini, A Castello, ... World journal of radiology 8 (10), 829, 2016 | 21 | 2016 |
| Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose A Campennì, E Amato, R Laudicella, A Alibrandi, D Cardile, SA Pignata, ... Endocrine 65, 132-137, 2019 | 13 | 2019 |
| Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223 O Caffo, V Frantellizzi, M Tucci, L Galli, F Monari, S Baldari, C Masini, ... European journal of nuclear medicine and molecular imaging 47, 2633-2638, 2020 | 8 | 2020 |
| Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer? A Campennì, SA Pignata, S Baldari Endocrine 50, 516-518, 2015 | 8 | 2015 |
| Usefulness of PET-CT scan in recurrent thyroid cancer G Dionigi, F Fama˘, SA Pignata, A Pino, A Pontin, E Caruso, Y Fu, S Li, ... World Journal of Otorhinolaryngology-Head and Neck Surgery 6 (03), 182-187, 2020 | 6 | 2020 |
| Predictive and prognostic value of left ventricular mechanical dyssynchrony assessed by myocardial perfusion single photon emission computed tomography in asymptomatic patients … F Caobelli, CE Popescu, R Laudicella, A Comis, SA Pignata, R Sara, ... Nuclear medicine communications 39 (5), 423-429, 2018 | 6 | 2018 |
| Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment SA Pignata, A Ferrantelli, S Baldari Clinical and Translational Imaging 7 (5), 373-376, 2019 | 5 | 2019 |
| Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical … A Campennì, RM Ruggeri, M Siracusa, SA Pignata, F Di Mauro, A Vento, ... Journal of Endocrinological Investigation 41, 1283-1288, 2018 | 4 | 2018 |
| Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer A Campennì, SA Pignata, S Baldari Clinical and Translational Imaging 6, 347-355, 2018 | 3 | 2018 |
| Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra O Caffo, V Frantellizzi, F Monari, L Galli, RP Costa, C Pinto, M Tucci, ... Cancer Biotherapy & Radiopharmaceuticals 36 (5), 391-396, 2021 | 2 | 2021 |
| Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients O Caffo, V Frantellizzi, F Monari, A Sbrana, RP Costa, C Pinto, M Tucci, ... Future Oncology 17 (7), 807-815, 2021 | 1 | 2021 |
| Peptide Receptor Radionuclide Therapy and Somatostatin'cold'Analogues Therapy in the Treatment of GEP-NET Patients: Our Center˘Experience S Pignata, A Campenni, R Laudicella, F Quattrocchi, A Comis, A Vento, ... 5th Theranostics World Congress 2019-Abstract book, [144]-[145], 2019 | 1 | 2019 |
| Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study … O Caffo, V Frantellizzi, L Galli, F Monari, G Facchini, S Baldari, M Tucci, ... Journal of Clinical Oncology 36 (6_suppl), 322-322, 2018 | 1 | 2018 |
